Analyst Ratings January 23, 2026

UBS Uplifts Intel Price Target to $52, Citing Strategic Foundry Prospects Amid Supply Challenges

Despite supply chain constraints and competitive pressures, Intel's foundry ambitions bolster analyst outlook

By Hana Yamamoto INTC AMD NVDA AAPL AMZN
UBS Uplifts Intel Price Target to $52, Citing Strategic Foundry Prospects Amid Supply Challenges
INTC AMD NVDA AAPL AMZN

UBS has increased its price projection for Intel stock to $52 from $49, reflecting enhanced confidence in Intel's potential to secure new foundry contracts following upcoming technology releases. However, persistent supply limitations and competitive disadvantages, especially against AMD, cloud Intel’s near-term server market opportunities. Other analysts also adjusted their outlooks post Intel's robust fourth-quarter performance, yet mixed views prevail due to ongoing operational pressures.

Key Points

  • UBS raised Intel's stock price target from $49 to $52, maintaining a Neutral rating despite a significant share price surge over the past year.
  • Intel struggles with supply limitations in server CPU production, particularly for Intel 7 technology-based Sapphire and Emerald Rapids processors, impacting its ability to capitalize on AI-related market growth.
  • The price target revision is influenced by optimism about Intel securing external foundry contracts following the anticipated 14A production design kit release, involving major industry players such as Nvidia, Apple, and Amazon.

UBS adjusted its price target for Intel Corporation (NASDAQ: INTC) upward to $52 from its previous recommendation of $49, while maintaining a Neutral stance on the stock. This adjustment follows a remarkable 151.8% rise in Intel’s share price over the last 12 months, including a notable 15.7% gain just in the previous week. Analysis from InvestingPro highlights that the current relative strength index (RSI) positions Intel as overbought, suggesting the stock might be trading above its intrinsic fair value.

UBS flagged production capacity constraints that Intel is currently facing, particularly in the first quarter. These limitations hamper the company's ability to meet growing demand for server CPUs. IBM’s server shipments mainly consist of Sapphire Rapids and Emerald Rapids processors, both fabricated using Intel 7 technology, which is confronting inherent challenges related to manufacturing yields.

Concerns voiced by UBS include Intel's potential to miss substantial AI-driven growth in the server market due to these supply bottlenecks and worsening structural disadvantages in comparison to competitor AMD. Additionally, while improvements in Intel’s personal computer product roadmap are evident, the overall PC market is projected to contract this year, exacerbated by high memory prices, reducing the potential positive impact.

Financially, Intel continues to generate profits with $53.4 billion in revenue over the last twelve months, though this figure reflects a slight 1.5% decline during the period.

UBS’s increased price target reflects a heightened expectation that Intel will finalize external foundry agreements later this year, following the anticipated launch of its 14A production design kit. Target customers referred to include major players such as Nvidia, Apple (notably for its M-Series chips), Amazon, and potentially a high-end consumer technology product.

However, UBS remains prudent regarding Intel’s earnings capacity. Approximately 50% of additional profitability is expected to be allocated to funds Apollo and Brookfield due to existing financing contracts. The transition to the 18A process technology is projected to improve foundry margins but may exert pressure on product-specific margins.

Intel's recent quarterly report revealed strong fourth-quarter results, with revenues reaching $13.7 billion and adjusted earnings per share at $0.15, both exceeding analyst estimates of $13.4 billion and $0.08 respectively. A significant contribution to this performance came from Intel’s Data Center and AI segment.

Following these developments, Stifel elevated its price target to $42 while retaining a Hold rating, Benchmark increased its target to $57 and maintained a Buy rating, and Truist Securities raised its price target to $49, emphasizing robust Data Center and AI revenue streams.

Conversely, Intel’s forecast for the first quarter fell short of consensus expectations due to ongoing supply shortages and high operating costs. Bernstein preserved its Market Perform rating with a $36 target, recognizing strong quarterly results but pointing to supply obstacles. TD Cowen kept its Hold rating with a $50 target, noting that recent stock market gains were driven more by future anticipation than current operational fundamentals.

These varying analyst perspectives illustrate a complex sentiment surrounding Intel’s stock, despite the company’s recent operational successes and strategic initiatives.

Risks

  • Intel’s supply constraints in the first quarter could hinder its capacity to meet demand in the server CPU market, potentially impacting revenue growth in data center and AI-related segments.
  • Competitive disadvantages versus AMD and an expected decline in the PC market, exacerbated by high memory prices, may limit Intel’s profitability and product uptake in key segments.
  • Financial arrangements with Apollo and Brookfield mean about half of incremental profits might be allocated to these funds, reducing potential earnings retention for Intel amid transitions to new process technologies that may negatively affect product margins.

More from Analyst Ratings

Evercore ISI Sticks with Outperform on Apple, Sets $330 Target Backed by App Store and Services Strength Feb 2, 2026 Deutsche Bank Says AppLovin Risk-Reward Looks Better After Google’s Project Genie Shock Feb 2, 2026 Raymond James Sticks With Market Perform on American Airlines Despite Stronger Guidance and Faster Debt Paydown Feb 2, 2026 Mizuho Sticks with Outperform on Robinhood as UK ISA Launch Seen as Growth Lever Feb 2, 2026 Freedom Capital Lifts Caterpillar Price Target to $700 but Keeps Hold Rating Feb 2, 2026